Advertisement

The Latest

For years, healthcare has been a major area of focus for private-equity investment, driving strong trends of consolidation within the industry. But a recent market analysis report from Pitchbook shows that momentum in healthcare specialist funds may be slowing down.

Physicians could lose at least $25 billion in add-on payments for Part B drugs that could be part of the Inflation Reduction Act's program to negotiate drugs, according to a recent study by Avalere. 

According to the Physician Foundation's annual "Survey of America's Current and Future Physicians," 6 in 10 physicians and residents reported experiencing burnout, and 50% of respondents said healthcare consolidation is having a negative impact on their job satisfaction. 

Advertisement